
Christopher Y. Kim
Examiner (ID: 18274)
| Most Active Art Unit | 1801 |
| Art Unit(s) | 1744, 2876, 1801, 1312 |
| Total Applications | 419 |
| Issued Applications | 342 |
| Pending Applications | 16 |
| Abandoned Applications | 61 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18428916
[patent_doc_number] => 11674127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Process of extracting oil from thin stillage
[patent_app_type] => utility
[patent_app_number] => 17/306001
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17336
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17306001
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/306001 | Process of extracting oil from thin stillage | May 2, 2021 | Issued |
Array
(
[id] => 18496209
[patent_doc_number] => 20230218773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-13
[patent_title] => ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/997453
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -86
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17997453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/997453 | ALBUMIN DRUG CONJUGATES AND USE THEREOF FOR THE TREATMENT OF CANCER | Apr 29, 2021 | Pending |
Array
(
[id] => 17045126
[patent_doc_number] => 11098295
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-08-24
[patent_title] => FCE mRNA capping enzyme compositions, methods and kits
[patent_app_type] => utility
[patent_app_number] => 17/246454
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11353
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17246454
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/246454 | FCE mRNA capping enzyme compositions, methods and kits | Apr 29, 2021 | Issued |
Array
(
[id] => 18434403
[patent_doc_number] => 20230181697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Use of Surfactant Protein D to Treat Viral Infections
[patent_app_type] => utility
[patent_app_number] => 17/920245
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920245 | Use of Surfactant Protein D to Treat Viral Infections | Apr 19, 2021 | Pending |
Array
(
[id] => 18434403
[patent_doc_number] => 20230181697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Use of Surfactant Protein D to Treat Viral Infections
[patent_app_type] => utility
[patent_app_number] => 17/920245
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920245 | Use of Surfactant Protein D to Treat Viral Infections | Apr 19, 2021 | Pending |
Array
(
[id] => 18434403
[patent_doc_number] => 20230181697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => Use of Surfactant Protein D to Treat Viral Infections
[patent_app_type] => utility
[patent_app_number] => 17/920245
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11764
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920245 | Use of Surfactant Protein D to Treat Viral Infections | Apr 19, 2021 | Pending |
Array
(
[id] => 17022566
[patent_doc_number] => 20210246437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => Compositions and Methods for Treating Celiac Sprue Disease
[patent_app_type] => utility
[patent_app_number] => 17/230230
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230230
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230230 | Compositions and Methods for Treating Celiac Sprue Disease | Apr 13, 2021 | Abandoned |
Array
(
[id] => 16992241
[patent_doc_number] => 20210230661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => IN VITRO GLYCOSYLATION OF PROTEINS AND ENZYMES
[patent_app_type] => utility
[patent_app_number] => 17/301590
[patent_app_country] => US
[patent_app_date] => 2021-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17301590
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/301590 | In vitro glycosylation of proteins and enzymes | Apr 7, 2021 | Issued |
Array
(
[id] => 18404586
[patent_doc_number] => 20230165937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-01
[patent_title] => GALECTIN-1 IMMUNOMODULATION AND MYOGENIC IMPROVEMENTS IN MUSCLE DISEASES AND AUTOIMMUINE DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/995794
[patent_app_country] => US
[patent_app_date] => 2021-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6958
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17995794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/995794 | GALECTIN-1 IMMUNOMODULATION AND MYOGENIC IMPROVEMENTS IN MUSCLE DISEASES AND AUTOIMMUINE DISORDERS | Apr 6, 2021 | Abandoned |
Array
(
[id] => 17336369
[patent_doc_number] => 20220002700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => COMPUTATIONALLY-OPTIMIZED ACE2 PEPTIDES FOR COMPETITIVE INTERCEPTION OF SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 17/222676
[patent_app_country] => US
[patent_app_date] => 2021-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/222676 | COMPUTATIONALLY-OPTIMIZED ACE2 PEPTIDES FOR COMPETITIVE INTERCEPTION OF SARS-CoV-2 | Apr 4, 2021 | Abandoned |
Array
(
[id] => 17228621
[patent_doc_number] => 20210355177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => MOLECULES FOR ORGANELLE-SPECIFIC PROTEIN DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/214757
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214757 | Molecules for organelle-specific protein delivery | Mar 25, 2021 | Issued |
Array
(
[id] => 18364665
[patent_doc_number] => 20230146256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/918835
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24634
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -68
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918835
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918835 | SARS-CoV-2 SPIKE RECEPTOR BINDING DOMAIN AND COMPOSITIONS AND METHODS THEREOF | Mar 24, 2021 | Pending |
Array
(
[id] => 18420442
[patent_doc_number] => 20230174904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => HIGHLY ALKALINE TEXTILE WASHING AGENT COMPRISING PROTEASE
[patent_app_type] => utility
[patent_app_number] => 17/920407
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19407
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920407 | Highly alkaline textile washing agent comprising protease | Mar 22, 2021 | Issued |
Array
(
[id] => 18391641
[patent_doc_number] => 20230159859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => HIGHLY ALKALINE TEXTILE DETERGENT COMPRISING PROTEASE
[patent_app_type] => utility
[patent_app_number] => 17/920410
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21513
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17920410
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/920410 | Highly alkaline textile detergent comprising protease | Mar 22, 2021 | Issued |
Array
(
[id] => 16932812
[patent_doc_number] => 20210198701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => FERMENTATIVE PRODUCTION OF ETHANOL FROM GLUCOSE, GALACTOSE AND ARABINOSE EMPLOYING A RECOMBINANT YEAST STRAIN
[patent_app_type] => utility
[patent_app_number] => 17/199823
[patent_app_country] => US
[patent_app_date] => 2021-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199823
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/199823 | Fermentative production of ethanol from glucose, galactose and arabinose employing a recombinant yeast strain | Mar 11, 2021 | Issued |
Array
(
[id] => 16961575
[patent_doc_number] => 20210213074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/196271
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17196271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/196271 | Compositions and methods for improving mitochondrial function | Mar 8, 2021 | Issued |
Array
(
[id] => 18333666
[patent_doc_number] => 20230125614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 17/905583
[patent_app_country] => US
[patent_app_date] => 2021-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905583
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/905583 | IN VIVO mRNA DISPLAY: LARGE-SCALE PROTEOMICS BY NEXT GENERATION SEQUENCING | Mar 4, 2021 | Pending |
Array
(
[id] => 20356252
[patent_doc_number] => 12472231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Compositions of anti-viral peptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/930626
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 26
[patent_no_of_words] => 10664
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930626 | Compositions of anti-viral peptides and methods of use thereof | Mar 1, 2021 | Issued |
Array
(
[id] => 20356252
[patent_doc_number] => 12472231
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Compositions of anti-viral peptides and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 17/930626
[patent_app_country] => US
[patent_app_date] => 2021-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 26
[patent_no_of_words] => 10664
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930626 | Compositions of anti-viral peptides and methods of use thereof | Mar 1, 2021 | Issued |
Array
(
[id] => 18350317
[patent_doc_number] => 20230138428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => CHIMERIC RECEPTORS FOR USE IN ENGINEERED CELLS
[patent_app_type] => utility
[patent_app_number] => 17/802018
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30128
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802018 | CHIMERIC RECEPTORS FOR USE IN ENGINEERED CELLS | Feb 23, 2021 | Pending |